Collaborative Neuroscience Research, LLC.

Los Alamitos, California 90720-3118

6 studies enrolling now · 20 studies all time

What they study most

Acute Venous and Arterial Thrombotic and Thromboembolic Events, Alzheimer Disease, Bipolar Disorder, Body Weight, COVID-19, Cardiovascular Diseases, Healthy, Healthy Participants, Healthy Volunteers, Influenza, Major Depressive Disorder (MDD), Nutrition Disorders

Studies at this site

• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight — Recruiting now
• A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia — Recruiting now
• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) — Recruiting now
• A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT — Recruiting now
• A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) — Recruiting now
• Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder — Completed
• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight — Completed
• A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects — Completed
• A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM — Completed
• A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode — Completed
• A Study of LY3537031 in Overweight, Obese, and Healthy Participants — Running, not enrolling
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. — Completed
• To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. — Completed
• A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants — Completed
• A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years — Completed
• A Preliminary Study to Evaluate PF-07264660 in Healthy Participants — Completed